Skip to main content

Request For Trial Preservation Depositions in DePuy Hip MDL

Request For Trial Preservation Depositions in DePuy Hip MDL

Request For Trial Preservation Depositions in DePuy Hip MDL

Introduction

In a supplemental memorandum filed on June 18, the plaintiffs in the DePuy hip multidistrict litigation requested permission to conduct trial preservation depositions for 11 defense witnesses. The plaintiffs asserted that the ongoing discovery, revelations, and new scientific literature warrant such depositions. The request was filed in the U.S. District Court for the Northern District of Texas.

DePuy and its parent corporation, Johnson & Johnson have been accused of failing to warn about device dislocation, loosening, and metallosis often requiring revision surgery. More than 9,400 Pinnacle hip lawsuits are pending in the federal court.

Other hip implant lawsuits include cases against Stryker hip replacement systems which are consolidated as a part of multidistrict litigation, MDL No. 2768 ( In Re: Stryker LFIT V40 Femoral Head Products Liability Litigation) in the United States District Court for the District of Massachusetts before U.S. District Judge Indira Talwani.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!